The Patent Finder
US

Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation

US 11,452,692 In force
OverviewFamilyAssignmentsSources & methods

Term ends Sep 27, 2039 · Low confidence

Filed Feb 3, 2022 as application 17/649,826 · Granted Sep 27, 2022
Base term, 20 years from filing
Today
20 years from filing
2019 2039
Clock starts
Sep 27, 2019
Term ends
Sep 27, 2039
Granted
Sep 27, 2022
base term fee events Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,925,832, to Sep 27, 2039. The term already ends on or before that date, so the cap shortened nothing.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Sep 27, 2019, when application 16/585,532, the earliest non-provisional in its chain, was filed (this one was filed Feb 3, 2022); a parent in its chain could not be resolved (the next row)Sep 27, 2039High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,925,832)resolves to Sep 27, 2039, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Further caveats on recordThe record names parents not resolved: 16585532, 16585532Low confidence overallLow confidence
Computed term endThe steps above, in orderSep 27, 2039Low confidence

This family

Application 62/738,333Provisional application
no patent term
no patent term
US 10,933,020In force
Sep 2039
Sep 2039
US 10,925,832In force
Sep 2039
Sep 2039
US 11,471,413In force
Sep 2039
Sep 2039
Application 17/167,714Abandoned
not computed
not computed
US 11,452,692this patent
Sep 2039
Sep 2039
US 11,890,378In force
Sep 2039
Sep 2039
US 12,558,317In force
Oct 2039
Oct 2039
8 of 9 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Feb 25, 2022
Reel 59105, frame 9
Betancourt, AimestherCorealis PharmaAssignment of Assignor's Interest
Feb 25, 2022
Reel 59105, frame 93
Thibert, RochCorealis PharmaAssignment of Assignor's Interest
Feb 25, 2022
Reel 59105, frame 201
Corealis PharmaKaruna Therapeutics, Inc.Assignment of Assignor's Interest
Feb 25, 2022
Reel 59105, frame 254
Rehlaender, BrucePharmadirections, Inc.Assignment of Assignor's Interest
Feb 25, 2022
Reel 59105, frame 386
Pharmadirections, Inc.Karuna Therapeutics, Inc.Assignment of Assignor's Interest
Oct 22, 2024
Reel 69205, frame 476
Karuna Therapeutics, Inc.Karuna Therapeutics, Inc.Certificate of Change of Assignee Principal Business Address

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited